2004
DOI: 10.1016/j.clim.2003.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Utilizing Fcε-Bak chimeric protein for studying IgE–FcεRI interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 34 publications
0
8
0
Order By: Relevance
“…DCs can be activated or inhibited through FcR by antibodies or immune complex formed by antibodies depending on the variations of FcR engaged. Activating and inhibitory IgG Fc receptors on DCs mediate opposing functions [17,18] DNA vaccination may directly target DCs involved in allergen-specific T H 1-cell responses, showing preventive effects when delivered in mice [19-23]. The vaccination with OVA-pcDNA 3.1 or OVA-Fc-pcDNA 3.1 showed preventive effects on OVA-induced hyper-production of IL-4 and IL-5 and hypo-production of INF-γ, and eosinophil infiltration, while the effects of OVA-Fc-pcDNA 3.1 were more significant.…”
Section: Discussionmentioning
confidence: 99%
“…DCs can be activated or inhibited through FcR by antibodies or immune complex formed by antibodies depending on the variations of FcR engaged. Activating and inhibitory IgG Fc receptors on DCs mediate opposing functions [17,18] DNA vaccination may directly target DCs involved in allergen-specific T H 1-cell responses, showing preventive effects when delivered in mice [19-23]. The vaccination with OVA-pcDNA 3.1 or OVA-Fc-pcDNA 3.1 showed preventive effects on OVA-induced hyper-production of IL-4 and IL-5 and hypo-production of INF-γ, and eosinophil infiltration, while the effects of OVA-Fc-pcDNA 3.1 were more significant.…”
Section: Discussionmentioning
confidence: 99%
“…The advantage of this strategy is that any type of IgE molecule, regardless of its specificity, can be targeted. The disadvantage is that, although the efficacy of nonanaphylactic, humanized anti-IgE antibodies in patients with asthma or peanut allergy [40][41][42] has been proven in different clinical studies, this treatment regimen will most probably be used as a concomitant therapy and not as a single treatment or as a single therapeutic option for acute allergic reactions.…”
Section: Fcgriib Puts the Brakes On Allergic Reactionsmentioning
confidence: 96%
“…The proapoptotic effect of the Fc3RI-Bak chimeric protein is directly dependent on the surface level of Fc3RI in the target cells, enabling the specific killing of Fc3RI-expressing cells [42,43]. These proapoptotic chimeric anti-Fc3RI proteins could possibly be used as a concomitant treatment of acute allergic diseases in the future.…”
Section: Fcgriib Puts the Brakes On Allergic Reactionsmentioning
confidence: 98%
See 1 more Smart Citation
“…It was shown to bind to FcεRI-expressing cells selectively, to be slowly internalized (within hours), and to kill cells by apoptosis [47].…”
Section: Anti-fcr and Fcr Ligandsmentioning
confidence: 99%